Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
Scientists design a promising vaccine for herpes viruses

Scientists design a promising vaccine for herpes viruses

New type of vaccine holds promise for prevention of genital herpes

New type of vaccine holds promise for prevention of genital herpes

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

SLU investigators find promising candidates for new herpes virus treatments

SLU investigators find promising candidates for new herpes virus treatments

Study reports effective treatment approach to inhibit herpes virus infection

Study reports effective treatment approach to inhibit herpes virus infection

Chemotherapy drug combined with cancer-killing virus may treat recurrent ovarian cancer

Chemotherapy drug combined with cancer-killing virus may treat recurrent ovarian cancer

Infection with herpes simplex virus increases Alzheimer's risk

Infection with herpes simplex virus increases Alzheimer's risk

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

Study: 15,000 pregnant women show decreased amount of prevalence of HSV type 2

Study: 15,000 pregnant women show decreased amount of prevalence of HSV type 2

Researchers examine association between ritual circumcision procedure and HSV-1 in infants

Researchers examine association between ritual circumcision procedure and HSV-1 in infants

Human herpes simplex virus infected human approximately 1.6 million years ago

Human herpes simplex virus infected human approximately 1.6 million years ago

PaxVax partners with UC to develop combination vaccine to prevent genital HSV infections

PaxVax partners with UC to develop combination vaccine to prevent genital HSV infections

Scientists develop microbicide gel that prevents transmission of multiple STIs in vagina/rectum in animals

Scientists develop microbicide gel that prevents transmission of multiple STIs in vagina/rectum in animals

Herpes simplex viral therapy in conjunction with radiation proves effective in treating malignant gliomas

Herpes simplex viral therapy in conjunction with radiation proves effective in treating malignant gliomas

Experimental vaccine for HSV-2 infection reduces rate of viral shedding at 6 months

Experimental vaccine for HSV-2 infection reduces rate of viral shedding at 6 months

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Women using DMPA injection more likely to acquire HIV than women using NET-EN

Women using DMPA injection more likely to acquire HIV than women using NET-EN

Researcher receives Pioneer Award for engineering herpes simplex virus gene delivery systems

Researcher receives Pioneer Award for engineering herpes simplex virus gene delivery systems

Admedus' HSV-2 therapeutic vaccine achieves primary endpoint in Phase 1 trial

Admedus' HSV-2 therapeutic vaccine achieves primary endpoint in Phase 1 trial

UT Southwestern' faculty receives Stanley J. Korsmeyer Award for contributions to understanding of autophagy

UT Southwestern' faculty receives Stanley J. Korsmeyer Award for contributions to understanding of autophagy